![Jan Willem Vrijbloed](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jan Willem Vrijbloed
Direttore Tecnico/Scientifico/R&S presso Neurotune AG
Profilo
Jan Willem Vrijbloed is currently working as the Director-Preclinical & Clinical Development at Neurotune AG.
Previously, he worked as a Principal at the University of Zurich and as the Head-Development at Spexis Ltd.
He holds a doctorate degree from the University of Groningen.
Posizioni attive di Jan Willem Vrijbloed
Società | Posizione | Inizio |
---|---|---|
Neurotune AG
![]() Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Direttore Tecnico/Scientifico/R&S | 04/11/2009 |
Precedenti posizioni note di Jan Willem Vrijbloed
Società | Posizione | Fine |
---|---|---|
SPEXIS AG | Corporate Officer/Principal | - |
University of Zurich | Corporate Officer/Principal | - |
Formazione di Jan Willem Vrijbloed
University of Groningen | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SPEXIS AG | Health Technology |
Aziende private | 1 |
---|---|
Neurotune AG
![]() Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Jan Willem Vrijbloed